These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7925784)

  • 21. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI.
    Yenari MA; Palmer JT; Sun GH; de Crespigny A; Mosely ME; Steinberg GK
    Brain Res; 1996 Nov; 739(1-2):36-45. PubMed ID: 8955922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
    Paris D; Quadros A; Humphrey J; Patel N; Crescentini R; Crawford F; Mullan M
    Brain Res; 2004 Feb; 999(1):53-61. PubMed ID: 14746921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
    Buchan AM; Gertler SZ; Huang ZG; Li H; Chaundy KE; Xue D
    Neuroscience; 1994 Jul; 61(1):1-11. PubMed ID: 7526264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride.
    Takakura S; Sogabe K; Satoh H; Mori J; Fujiwara T; Totsuka Z; Tokuma Y; Kohsaka M
    Neurosci Lett; 1992 Jul; 141(2):199-202. PubMed ID: 1436634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia.
    Korenkov AI; Pahnke J; Frei K; Warzok R; Schroeder HW; Frick R; Muljana L; Piek J; Yonekawa Y; Gaab MR
    Neurosurg Rev; 2000 Sep; 23(3):145-50. PubMed ID: 11086739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
    Pei Z; Pang SF; Cheung RT
    Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia.
    Cao X; Phillis JW
    Brain Res; 1994 May; 644(2):267-72. PubMed ID: 8050038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia.
    Hosomi N; Nishiyama A; Ban CR; Naya T; Takahashi T; Kohno M; Koziol JA
    Neuroscience; 2005; 134(1):225-31. PubMed ID: 15963646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model.
    Takahara A; Konda T; Enomoto A; Kondo N
    Biol Pharm Bull; 2004 Sep; 27(9):1388-91. PubMed ID: 15340224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.
    Savitz SI; Erhardt JA; Anthony JV; Gupta G; Li X; Barone FC; Rosenbaum DM
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1197-204. PubMed ID: 10950380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
    Moriyama T; Oka K; Ueda H; Imai E
    Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo effects of the Ca2+ entry blocker nilvadipine on brain surface microvessels in rats.
    Kawamura S; Yasui N
    Neurol Med Chir (Tokyo); 1994 Oct; 34(10):663-7. PubMed ID: 7529366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine.
    Tsuchihashi T; Tsukashima A; Matsumura K; Abe I; Tominaga M; Nakao Y; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1991; 41(3):255-7. PubMed ID: 1748143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification.
    Barone FC; Hillegass LM; Price WJ; White RF; Lee EV; Feuerstein GZ; Sarau HM; Clark RK; Griswold DE
    J Neurosci Res; 1991 Jul; 29(3):336-45. PubMed ID: 1656059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fentanyl does not increase brain injury after focal cerebral ischemia in rats.
    Soonthon-Brant V; Patel PM; Drummond JC; Cole DJ; Kelly PJ; Watson M
    Anesth Analg; 1999 Jan; 88(1):49-55. PubMed ID: 9895065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats.
    Lee EJ; Chen HY; Wu TS; Chen TY; Ayoub IA; Maynard KI
    J Neurosci Res; 2002 Jun; 68(5):636-45. PubMed ID: 12111854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.